APA

Leblond V., Morel P., Dilhuidy M., Leleu X., Soussain C., Leprête S., Dreyfus B., Dartigeas C., Mahé B., Anglaret B., Pégourié B., Besson C., Aurran T., Vekhoff A., Tournilhac O., Banos A., Oya H., Lejeune J., Ouzegdouh M. & Chevret S. (20180417). A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone. : Leukemia & lymphoma.

Chicago

Leblond Véronique, Morel Pierre, Dilhuidy Marie-Sarah, Leleu Xavier, Soussain Carole, Leprête Stéphane, Dreyfus Brigitte, Dartigeas Caroline, Mahé Béatrice, Anglaret Bruno, Pégourié Brigitte, Besson Caroline, Aurran Thérèse, Vekhoff Anne, Tournilhac Olivier, Banos Anne, Oya Hervé, Lejeune Julie, Ouzegdouh Maya and Chevret Sylvie. 20180417. A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone. : Leukemia & lymphoma.

Harvard

Leblond V., Morel P., Dilhuidy M., Leleu X., Soussain C., Leprête S., Dreyfus B., Dartigeas C., Mahé B., Anglaret B., Pégourié B., Besson C., Aurran T., Vekhoff A., Tournilhac O., Banos A., Oya H., Lejeune J., Ouzegdouh M. and Chevret S. (20180417). A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone. : Leukemia & lymphoma.

MLA

Leblond Véronique, Morel Pierre, Dilhuidy Marie-Sarah, Leleu Xavier, Soussain Carole, Leprête Stéphane, Dreyfus Brigitte, Dartigeas Caroline, Mahé Béatrice, Anglaret Bruno, Pégourié Brigitte, Besson Caroline, Aurran Thérèse, Vekhoff Anne, Tournilhac Olivier, Banos Anne, Oya Hervé, Lejeune Julie, Ouzegdouh Maya and Chevret Sylvie. A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone. : Leukemia & lymphoma. 20180417.